Lifestyle

Lilly Sues Four Compounders Over Copies of Weight-Loss Drugs

Published

8 months ago

on

Eli Lilly announced Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, the main ingredient in Lilly’s weight-loss and diabetes medicines, after a US judge blocked copies when not in times of shortage.
Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending

Exit mobile version